Tailor-Made Hydrogels for Tumor Delivery

Drug Delivery in Oncology: From Basic Research to Cancer Therapy

Volumn 2, Issue , 2011, Pages 1071-1097

  Kim, Sungwon ^a   Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cancer therapy; Drug delivery; Hydrogel; Nanogel

Indexed keywords

EID: 84887135598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527634057.ch33     Document Type: Chapter

References (104)

1. Wichterle, O. and Lim, D. (1960) Hydrophilic gels for biological use. Nature, 185, 117-118.
2. Kim, S.W., Bae, Y.H., and Okano, T. (1992) Hydrogels - swelling, drug loading, and release. Pharm. Res., 9, 283-290.
3. Kou, J.H., Amidon, G.L., and Lee, P.I. (1988) pH-dependent swelling and solute diffusion characteristics of poly(hydroxyethyl methacrylate-co-methacrylic acid) hydrogels. Pharm. Res., 5, 592-597.
4. Berge, S.J., Wiese, K.G., von Lindern, J.J., Niederhagen, B., Appel, T., and Reich, R.H. (2001) Tissue expansion using osmotically active hydrogel systems for direct closure of the donor defect of the radial forearm flap. Plast. Reconstr. Surg., 108, 1-5.
5. Obdeijn, M.C., Nicolai, J.P., and Werker, P.M. (2009) The osmotic tissue expander: a three-year clinical experience. J. Plast. Reconstr. Aesthet. Surg., 62, 1219-1222.
6. Andrade, J.D. and Hlady, V. (1986) Protein adsorption and materials biocompatibility - a tutorial review and suggested hypotheses. Adv. Polym. Sci., 79, 1-63.
7. Lipinski, C.A. (2000) Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Method, 44, 235-249.
8. Lin, C.C. and Metters, A.T. (2006) Hydrogels in controlled release formulations: network design and mathematical modeling. Adv. Drug. Deliv. Rev., 58, 1379-1408.
9. Konishi, M., Tabata, Y., Kariya, M., Suzuki, A., Mandai, M., Nanbu, K., Takakura, K., and Fujii, S. (2003) In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J. Control. Release, 92, 301-313.
10. Lalloo, A., Chao, P., Hu, P., Stein, S., and Sinko, P.J. (2006) Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. J. Control. Release, 112, 333-342.
11. Li, X., Kong, X., Zhang, J., Wang, Y., Shi, S., Guo, G., Luo, F., Zhao, X., Wei, Y., and Qian, Z. (2011) A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids. J. Pharm. Sci., 100, 232-241.
12. Obara, K., Ishihara, M., Ozeki, Y., Ishizuka, T., Hayashi, T., Nakamura, S., Saito, Y., Yura, H., Matsui, T., Hattori, H., Takase, B., Kikuchi, M., and Maehara, T. (2005) Controlled release of paclitaxel from photocrosslinked chitosan hydrogelsand its subsequent effect on subcutaneous tumor growth in mice. J. Control. Release, 110, 79-89.
13. Ta, H.T., Dass, C.R., Larson, I., Choong, P.F., and Dunstan, D.E. (2009) A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma. Biomaterials, 30, 3605-3613.
14. Ruel-Gariepy, E., Shive, M., Bichara, A., Berrada, M., Le Garrec, D., Chenite, A., and Leroux, J.C. (2004) A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm. Biopharm., 57, 53-63.
15. Redpath, M., Marques, C.M., Dibden, C., Waddon, A., Lalla, R., and Macneil, S. (2009) Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells. Br. J. Dermatol., 161, 25-33.
16. Kwak, M.K., Hur, K., Yu, J.E., Han, T.S., Yanagihara, K., Kim, W.H., Lee, S.M., Song, S.C., and Yang, H.K. (2010) Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent. Invest. New Drugs, 28, 284-290.
17. Shim, W.S., Kim, J.H., Kim, K., Kim, Y.S., Park, R.W., Kim, I.S., Kwon, I.C., and Lee, D.S. (2007) pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Int. J. Pharm., 331, 11-18.
18. Wang, Y., Gong, C., Yang, L., Wu, Q., Shi, S., Shi, H., Qian, Z., and Wei, Y. (2010) 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. BMC Cancer, 10, 402.
19. St'astny, M., Plocova, D., Etrych, T., Kovar, M., Ulbrich, K., and Rihova, B. (2002) HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy. J. Control. Release, 81, 101-111.
20. St'astny, M., Plocova, D., Etrych, T., Ulbrich, K., and Rihova, B. (2002) HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia. Eur. J. Cancer, 38, 602-608.
21. Yu, L., Chang, G.T., Zhang, H., and Ding, J.D. (2008) Injectable block copolymer hydrogels for sustained release of a PEGylated drug. Int. J. Pharm., 348, 95-106.
22. Chun, C., Lee, S.M., Kim, C.W., Hong, K.Y., Kim, S.Y., Yang, H.K., and Song, S.C. (2009) Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics. Biomaterials, 30, 4752-4762.
23. Al-Abd, A.M., Hong, K.Y., Song, S.C., and Kuh, H.J. (2010) Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J. Control. Release, 142, 101-107.
24. Cho, Y.I., Park, S., Jeong, S.Y., and Yoo, H.S. (2009) In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates. Eur. J. Pharm. Biopharm., 73, 59-65.
25. Varghese, O.P., Sun, W., Hilborn, J., and Ossipov, D.A. (2009) In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. J. Am. Chem. Soc., 131, 8781-8783.
26. Schlegel, P.N., Kuzma, P., Frick, J., Farkas, A., Gomahr, A., Spitz, I., Chertin, B., Mack, D., Jungwirth, A., King, P., Nash, H., Bardin, C.W., and Moo-Young, A. (2001) Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin. Urology, 58, 578-582.
27. Liu, L., Sakaguchi, T., Kanda, T., Hitomi, J., Tabata, Y., and Hatakeyama, K. (2003) Delivery of interleukin-12 in gelatin hydrogels effectively suppresses development of transplanted colonal carcinoma in mice. Cancer Chemother. Pharmacol., 51, 53-57.
28. Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.M., Noel, A., Boniver, J., and Delvenne, P. (2004) Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrob. Agents Chemother., 48, 4342-4348.
29. Liu, Q., Shuhendler, A., Cheng, J., Rauth, A.M., O'Brien, P., and Wu, X.Y. (2010) Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells. Breast Cancer Res. Treat., 121, 323-333.
30. Hyoudou, K., Nishikawa, M., Ikemura, M., Kobayashi, Y., Mendelsohn, A., Miyazaki, N., Tabata, Y., Yamashita, F., and Hashida, M. (2009) Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase. J. Control. Release, 137, 110-115.
31. Hyoudou, K., Nishikawa, M., Ikemura, M., Kobayashi, Y., Mendelsohn, A., Miyazaki, N., Tabata, Y., Yamashita, F., and Hashida, M. (2007) Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells. J. Control. Release, 122, 151-158.
32. Seo, S.H., Han, H.D., Noh, K.H., Kim, T.W., and Son, S.W. (2009) Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity. Clin. Exp. Metastasis, 26, 179-187.
33. Han, H.D., Song, C.K., Park, Y.S., Noh, K.H., Kim, J.H., Hwang, T., Kim, T.W., and Shin, B.C. (2008) A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int. J. Pharm., 350, 27-34.
34. Ta, H.T., Dass, C.R., Larson, I., Choong, P.F., and Dunstan, D.E. (2009) A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials, 30, 4815-4823.
35. Krebs, M.D., Jeon, O., and Alsberg, E. (2009) Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J. Am. Chem. Soc., 131, 9204-9206.
36. Megeed, Z., Haider, M., Li, D., O'Malley Jr., B.W., Cappello, J., and Ghandehari, H. (2004) In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J. Control. Release, 94, 433-445.
37. Hatefi, A., Cappello, J., and Ghandehari, H. (2007) Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers. Pharm. Res., 24, 773-779.
38. Li, A.A., Shen, F., Zhang, T., Cirone, P., Potter, M., and Chang, P.L. (2006) Enhancement of myoblast microencapsulation for gene therapy. J. Biomed. Mater. Res. B, 77, 296-306.
39. Wang, C., Adrianus, G.N., Sheng, N., Toh, S., Gong, Y., and Wang, D.A. (2009) In vitro performance of an injectable hydrogel/microsphere based immunocyte delivery system for localised anti-tumour activity. Biomaterials, 30, 6986-6995.
40. Azhdarinia, A., Yang, D.J., Yu, D.F., Mendez, R., Oh, C., Kohanim, S., Bryant, J., and Kim, E.E. (2005) Regional radiochemotherapy using in situ hydrogel. Pharm. Res., 22, 776-783.
41. Horak, D., Guseinov, E., Vishnevskii, V., Adamyan, A., Kokov, L., Tsvirkun, V., Tchjao, A., Titova, M., Skuba, N., Trostenyuk, N., and Gumargalieva, K. (2000) Targeted chemoembolization of tumors with poly(2-hydroxyethyl methacrylate) particles. J. Biomed. Mater. Res., 51, 184-190.
42. Phadke, R.V., Venkatesh, S.K., Kumar, S., Tandon, V., Pandey, R., Tyagi, I., Jain, V.K., and Chhabra, D.K. (2002) Embolization of cranial/spinal tumours and vascular malformations with hydrogel microspheres. An experience of 69 cases. Acta Radiol., 43, 15-20.
43. van Es, R.J., Nijsen, J.F., Dullens, H.F., Kicken, M., van der Bilt, A., Hennink, W., Koole, R., and Slootweg, P.J. (2001) Tumour embolization of the Vx2 rabbit head and neck cancer model with dextran hydrogel and holmium-poly (l -lactic acid) microspheres: a radionuclide and histological pilot study. J. Craniomaxillofac. Surg., 29, 289-297.
44. Le Renard, P.E., Jordan, O., Faes, A., Petri-Fink, A., Hofmann, H., Rufenacht, D., Bosman, F., Buchegger, F., and Doelker, E. (2010) The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials, 31, 691-705.
45. Chaterji, S., Kwon, I.K., and Park, K. (2007) Smart polymeric gels: redefining the limits of biomedical devices. Prog. Polym. Sci., 32, 1083-1122.
46. Banta, S., Wheeldon, I.R., and Blenner, M. (2010) Protein engineering in the development of functional hydrogels. Annu. Rev. Biomed. Eng., 12, 167-186.
47. Ehrick, J.D., Deo, S.K., Browning, T.W., Bachas, L.G., Madou, M.J., and Daunert, S. (2005) Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat. Mater., 4, 298-302.
48. Burkoth, A.K. and Anseth, K.S. (2000) A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials, 21, 2395-2404.
49. Davis, N.E., Ding, S., Forster, R.E., Pinkas, D.M., and Barron, A.E. (2010) Modular enzymatically crosslinked protein polymer hydrogels for in situ gelation. Biomaterials, 31, 7288-7297.
50. Jeong, B., Kim, S.W., and Bae, Y.H. (2002) Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev., 54, 37-51.
51. Nguyen, K.T., Shukla, K.P., Moctezuma, M., Braden, A.R., Zhou, J., Hu, Z., and Tang, L. (2009) Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells. J. Biomed. Mater. Res. A, 88, 1022-1030.
52. Lakshmi, S., Katti, D.S., and Laurencin, C.T. (2003) Biodegradable polyphosphazenes for drug delivery applications. Adv. Drug Deliv. Rev., 55, 467-482.
53. Ta, H.T., Dass, C.R., and Dunstan, D.E. (2008) Injectable chitosan hydrogels for localised cancer therapy. J. Control. Release, 126, 205-216.
54. Shidhaye, S., Lotlikar, V., Malke, S., and Kadam, V. (2008) Nanogel engineered polymeric micelles for drug delivery. Curr. Drug Ther., 3, 209-217.
55. Hamidi, M., Azadi, A., and Rafiei, P. (2008) Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev., 60, 1638-1649.
56. Kim, S., Park, K.M., Ko, J.Y., Kwon, I.C., Cho, H.G., Kang, D., Yu, I.T., Kim, K., and Na, K. (2008) Minimalism in fabrication of self-organized nanogels holding both anti-cancer drug and targeting moiety. Colloids Surf. B, 63, 55-63.
57. Na, K., Park, K.H., Kim, S.W., and Bae, Y.H. (2000) Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J. Control. Release, 69, 225-236.
58. Oh, N.M., Oh, K.T., Baik, H.J., Lee, B.R., Lee, A.H., Youn, Y.S., and Lee, E.S. (2010) A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation. Colloids Surf. B, 78, 120-126.
59. Park, W., Park, S.J., and Na, K. (2010) Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier. Colloids Surf. B, 79, 501-508.
60. Huang, S.J., Sun, S.L., Feng, T.H., Sung, K.H., Lui, W.L., and Wang, L.F. (2009) Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier. Eur. J. Pharm. Sci., 38, 64-73.
61. Ray, D., Mohapatra, D.K., Mohapatra, R.K., Mohanta, G.P., and Sahoo, P.K. (2008) Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosizedhydrogel. J. Biomater. Sci. Polym. Ed., 19, 1487-1502.
62. Oishi, M. and Nagasaki, Y. (2010) Stimuli-responsive smart nanogels for cancer diagnostics and therapy. Nanomedicine, 5, 451-468.
63. Na, K., Lee, E.S., and Bae, Y.H. (2007) Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells. Bioconjug. Chem., 18, 1568-1574.
64. Yu, J., Lee, H.J., Hur, K., Kwak, M.K., Han, T.S., Kim, W.H., Song, S.C., Yanagihara, K., and Yang, H.K. (2010) The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. Invest. New Drugs, Epub ahead of print. DOI: 10.1007/s10637- 010-9499-y.
65. Cho, J., Heuzey, M.C., Begin, A., and Carreau, P.J. (2005) Physical gelation of chitosan in the presence of beta-glycerophosphate: the effect of temperature. Biomacromolecules, 6, 3267-3275.
66. Ishihara, M., Obara, K., Nakamura, S., Fujita, M., Masuoka, K., Kanatani, Y., Takase, B., Hattori, H., Morimoto, Y., Maehara, T., and Kikuchi, M. (2006) Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J. Artif. Organs, 9, 8-16.
67. Kim, J.Y., Kim, S., Papp, M., Park, K., and Pinal, R. (2010) Hydrotropic solubilization of poorly water-soluble drugs. J. Pharm. Sci., 99, 3953-3965.
68. Cruise, G.M., Scharp, D.S., and Hubbell, J.A. (1998) Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials, 19, 1287-1294.
69. Hoare, T.R. and Kohane, D.S. (2008) Hydrogels in drug delivery: progress and challenges. Polymer, 49, 1993-2007.
70. Ranganath, S.H., Kee, I., Krantz, W.B., Chow, P.K., and Wang, C.H. (2009) Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy. Pharm. Res., 26, 2101-2114.
71. Fang, F., Gong, C., Qian, Z., Zhang, X., Gou, M., You, C., Zhou, L., Liu, J., Zhang, Y., Guo, G., Gu, Y., Luo, F., Chen, L., Zhao, X., and Wei, Y. (2009) Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano, 3, 4080-4088.
72. Davis, M.E. and Brewster, M.E. (2004) Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov., 3, 1023-1035.
73. Stella, V.J. and Nti-Addae, K.W. (2007) Prodrug strategies to overcome poor water solubility. Adv. Drug Deliv. Rev., 59, 677-694.
74. Rihova, B., Srogl, J., Jelinkova, M., Hovorka, O., Buresova, M., Subr, V., and Ulbrich, K. (1997) HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibility. Ann. NY Acad. Sci., 831, 57-71.
75. Screnci, D., McKeage, M.J., Galettis, P., Hambley, T.W., Palmer, B.D., and Baguley, B.C. (2000) Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br. J. Cancer, 82, 966-972.
76. Casolaro, M., Cini, R., Del Bello, B., Ferrali, M., and Maellaro, E. (2009) Cisplatin/hydrogel complex in cancer therapy. Biomacromolecules, 10, 944-949.
77. Tauro, J.R. and Gemeinhart, R.A. (2005) Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug. Chem., 16, 1133-1139.
78. Fang, J.Y., Chen, J.P., Leu, Y.L., and Hu, J.W. (2008) The delivery of platinum drugs from thermosensitive hydrogels containing different ratios of chitosan. Drug Deliv., 15, 235-243.
79. Ye, M., Kim, S., and Park, K. (2010) Issues in long-term protein delivery using biodegradable microparticles. J. Control. Release, 146, 241-260.
80. Mellott, M.B., Searcy, K., and Pishko, M.V. (2001) Release of proteinfrom highly cross-linked hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization. Biomaterials, 22, 929-941.
81. Lu, Y., Yang, J., and Sega, E. (2006) Issues related to targeted delivery of proteins and peptides. AAPS J., 8, E466-E478.
82. Zhang, Y., Schulte, W., Pink, D., Phipps, K., Zijlstra, A., Lewis, J.D., and Waisman, D.M. (2010) Sensitivity of cancer cells to truncated diphtheria toxin. PLoS ONE, 5, e10498.
83. Kikuchi, T., Joki, T., Abe, T., and Ohno, T. (1999) Antitumor activity of killer cells stimulated with both interleukin-2 and interleukin-12 on mouse glioma cells. J. Immunother., 22, 245-250.
84. Hamilton, J.A. (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol., 23, 403-408.
85. Wu, W.S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev., 25, 695-705.
86. Li, Z., Wang, F., Roy, S., Sen, C.K., and Guan, J. (2009) Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. Biomacromolecules, 10, 3306-3316.
87. Fridmans, A., Chertin, B., Koulikov, D., Lindenberg, T., Gelber, H., Leiter, C., Farkas, A., and Spitz, I.M. (2005) Reversibility of androgen deprivation therapy in patients with prostate cancer. J. Urol., 173, 784-789.
88. Vile, R.G., Russell, S.J., and Lemoine, N.R. (2000) Cancer gene therapy: hard lessons and new courses. Gene Ther., 7, 2-8.
89. Schmidt, J.J., Rowley, J., and Kong, H.J. (2008) Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. A, 87, 1113-1122.
90. Matsumoto, G. and Shindo, J. (2001) Cancer therapy by gene therapy with angiostatin. Drugs Today, 37, 815-821.
91. Bae, B.C. and Na, K. (2010) Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials, 31, 6325-6335.
92. Li, F., Bae, B.C., and Na, K. (2010) Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells. Bioconjug. Chem., 21, 1312-1320.
93. Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerner, T., Felix, R., and Riess, H. (2002) The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol., 43, 33-56.
94. Nakamura, T., Tamura, A., Murotani, H., Oishi, M., Jinji, Y., Matsuishi, K., and Nagasaki, Y. (2010) Large payloads of gold nanoparticles into the polyamine network core of stimuli-responsive PEGylated nanogels for selective and noninvasive cancer photothermal therapy. Nanoscale, 2, 739-746.
95. Yang, Z., Leon, J., Martin, M., Harder, J.W., Zhang, R., Liang, D., Lu, W., Tian, M., Gelovani, J.G., Qiao, A., and Li, C. (2009) Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology, 20, 165101.
96. Zhang, J., Chen, H., Xu, L., and Gu, Y. (2008) The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model. J. Control. Release, 131, 34-40.
97. Wang, J., Loh, K.P., Wang, Z., Yan, Y., Zhong, Y., Xu, Q.H., and Ho, P.C. (2009) Fluorescent nanogel of arsenic sulfide nanoclusters. Angew. Chem. Int. Ed. Engl., 48, 6282-6285.
98. Gaur, U., Sahoo, S.K., De, T.K., Ghosh, P.C., Maitra, A., and Ghosh, P.K. (2000) Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int. J. Pharm., 202, 1-10.
99. Mitra, S., Gaur, U., Ghosh, P.C., and Maitra, A.N. (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release, 74, 317-323.
100. Wu, W., Shen, J., Banerjee, P., and Zhou, S. (2010) Core-shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment. Biomaterials, 31, 7555-7566.
101. Bhardwaj, U., Papadimitrakopoulos, F., and Burgess, D.J. (2008) A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. J. Diabetes Sci. Technol., 2, 1016-1029.
102. Huang, H., Qi, Z., Deng, L., Zhou, G., Kajiyama, T., and Kambara, H. (2009) Highly sensitive mutation detection based on digital amplification coupled with hydrogel bead-array. Chem. Commun., 4094-4096.
103. Fischbach, C., Kong, H.J., Hsiong, S.X., Evangelista, M.B., Yuen, W., and Mooney, D.J. (2009) Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. USA, 106, 399-404.
104. Xu, X. and Prestwich, G.D. (2010) Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer, 116, 1739-1750.